LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Normalized Growth Rate Inhibition Value | Standard Error of the Mean for Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP5 | 0.3253 | 0.0358 | -0.1245 | 0.0878 |
| SK-BR-3 | Mitoxantrone | 1.11 | uM | LJP6 | 0.3014 | 0.0318 | -0.2034 | 0.1156 |
| SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP5 | 0.2270 | 0.0220 | -0.3271 | 0.0539 |
| SK-BR-3 | Mitoxantrone | 3.33 | uM | LJP6 | 0.2181 | 0.0398 | -0.3792 | 0.0993 |
| SK-BR-3 | Mitoxantrone | 10 | uM | LJP5 | 0.0916 | 0.0421 | -0.6796 | 0.1080 |
| SK-BR-3 | Mitoxantrone | 10 | uM | LJP6 | 0.0768 | 0.0374 | -0.7340 | 0.1000 |
| SK-BR-3 | Radicicol | 0.04 | uM | LJP5 | 0.5936 | 0.0324 | 0.3664 | 0.0269 |
| SK-BR-3 | Radicicol | 0.04 | uM | LJP6 | 0.5639 | 0.0279 | 0.2910 | 0.0140 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP5 | 0.4496 | 0.0144 | 0.1123 | 0.0401 |
| SK-BR-3 | Radicicol | 0.12 | uM | LJP6 | 0.4384 | 0.0253 | 0.0624 | 0.0592 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP5 | 0.4199 | 0.0131 | 0.0558 | 0.0635 |
| SK-BR-3 | Radicicol | 0.37 | uM | LJP6 | 0.4052 | 0.0273 | 0.0000 | 0.0643 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP5 | 0.4019 | 0.0260 | 0.0188 | 0.0889 |
| SK-BR-3 | Radicicol | 1.11 | uM | LJP6 | 0.3841 | 0.0247 | -0.0412 | 0.0887 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 0.3964 | 0.0106 | 0.0102 | 0.0590 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP6 | 0.3860 | 0.0194 | -0.0371 | 0.0650 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 0.3253 | 0.0398 | -0.1231 | 0.0170 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 0.2996 | 0.0420 | -0.2088 | 0.0134 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 0.9962 | 0.0105 | 0.9949 | 0.0151 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 1.0607 | 0.0127 | 1.0943 | 0.0248 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 0.9697 | 0.0473 | 0.9438 | 0.0677 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 0.8963 | 0.0147 | 0.8404 | 0.0203 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 0.5171 | 0.0578 | 0.2327 | 0.0882 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 0.4680 | 0.0439 | 0.1160 | 0.0819 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 0.3509 | 0.0141 | -0.0741 | 0.0848 |